series-a
Stage
About
Leuko develops PointCheck™, a noninvasive device that uses light and AI to monitor white blood cell levels, enabling early detection of infection risk primarily for cancer patients at home.
Explore Leuko's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.